Literature DB >> 16451086

Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure.

Hanna Kumpulainen1, Niina Mähönen, Marja-Leena Laitinen, Marja Jaurakkajärvi, Hannu Raunio, Risto O Juvonen, Jouko Vepsäläinen, Tomi Järvinen, Jarkko Rautio.   

Abstract

Hydroxyimine derivatives of ketoprofen (1) and nabumetone (2) were synthesized and evaluated in vitro and in vivo as cytochrome P450-selective intermediate prodrug structures of ketones. 2 released nabumetone in vitro in the presence of isolated rat and human liver microsomes and in different recombinant human CYP isoforms. Bioconversion of 2 to both nabumetone and its active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA), was further confirmed in rats in vivo. Results indicate that hydroxyimine is a useful intermediate prodrug structure for ketone drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451086     DOI: 10.1021/jm0510124

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Alcohol, Aldehyde, and Ketone Liberation and Intracellular Cargo Release through Peroxide-Mediated α-Boryl Ether Fragmentation.

Authors:  Ramsey D Hanna; Yuta Naro; Alexander Deiters; Paul E Floreancig
Journal:  J Am Chem Soc       Date:  2016-09-30       Impact factor: 15.419

2.  Antitumor activity of DMAKO-05, a novel shikonin derivative, and its metabolism in rat liver microsome.

Authors:  Xu Zhang; Ru-Bing Wang; Wen Zhou; Sui Xiao; Qing-Qing Meng; Shao-Shun Li
Journal:  AAPS PharmSciTech       Date:  2014-10-02       Impact factor: 3.246

3.  Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs.

Authors:  Bryan T Mott; Abhai Tripathi; Maxime A Siegler; Cathy D Moore; David J Sullivan; Gary H Posner
Journal:  J Med Chem       Date:  2013-03-07       Impact factor: 7.446

4.  Targeting ketone drugs towards transport by the intestinal peptide transporter, PepT1.

Authors:  David Foley; Patrick Bailey; Myrtani Pieri; David Meredith
Journal:  Org Biomol Chem       Date:  2009-01-21       Impact factor: 3.876

Review 5.  Enzyme Models-From Catalysis to Prodrugs.

Authors:  Zeinab Breijyeh; Rafik Karaman
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

6.  Synthesis, screening and pharmacokinetic evaluation of potential prodrugs of bupropion. Part one: in vitro development.

Authors:  Paul Matthew O'Byrne; Robert Williams; John J Walsh; John F Gilmer
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-14

7.  Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph-Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice.

Authors:  Francesca Ferlenghi; Carmine Giorgio; Matteo Incerti; Lorenzo Guidetti; Paola Chiodelli; Marco Rusnati; Massimiliano Tognolini; Federica Vacondio; Marco Mor; Alessio Lodola
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.